K-numberK242056
Device namemiacare (DELiGHT daily wear/ DELiGHT 1-day/ CONFiDENCE Color daily wear/CONFiDENCE Color 1-day) Contact Lens with EautraSil Plus
ApplicantBenq Materials Corporation
Product codeLPL
Device classClass II
Decision dateApr 17, 2025
DecisionSubstantially Equivalent
Regulation886.5925
AI Summary extracted from FDA summary PDF · never regenerated
Intended use

These are soft silicone hydrogel contact lenses (miafilcon A and B) in four variants: daily wear and daily disposable, each available in clear or color-enhancing versions. They correct refractive errors (myopia and hyperopia) in non-diseased eyes with minimal astigmatism (≤1.00D) and include UV-blocking capability.

Technological characteristics

Both miafilcon A (46% water content, Dk 155) and miafilcon B (48% water content, Dk 121) are spherical, cast-molded silicone hydrogels with comparable refractive indices (1.407 and 1.405 respectively), matching the predicate devices in diameter (13.0–15.0 mm), base curve (8.0–9.2 mm), and power range (-12.00D to +8.00D). The main difference is the lens material composition, though physical properties and oxygen permeability remain similar to predicates.

Test standards cited

ISO 18369 (contact lens specifications), ISO 10993 series (biocompatibility: cytotoxicity, sensitization, acute toxicity, ocular irritation), and ISO 9394 (22-day rabbit contact lens wear study).

Substantial equivalence argument

Although the lens material (miafilcon A and B copolymers) differs from the predicate (olifilcon A/B), non-clinical biocompatibility and physiochemical testing demonstrated acceptable safety profiles. Clinical studies in 192 subjects per arm showed no statistically significant differences versus predicates in adverse events, visual acuity, keratometry, or wear tolerance over 90 days. Both test and control groups achieved corrected visual acuity ≥1.0 with comparable safety endpoints, establishing functional and performance equivalence despite material differences.

Extracted by AI from the official FDA summary PDF →
Source

View the full FDA submission: accessdata.fda.gov

Researching this as a predicate?
Want a transparent AI-ranking score, AI-discovered related predicates, ongoing safety and warning-letter monitoring, full predicate chain lineage, and a drafted SE rationale — all saved to your own project? That's what an account adds.
Start free trial →

Everything you need for a 510(k) submission. Nothing you don't.

14-day free trial. No setup. Cancel anytime.

Start free trial →
Building an AI or ML-enabled device? Predicate search, PCCP tracking, and AI-specific FDA intelligence — built exclusively for AI/ML devices. Try AIFDA Intel →